LTI Threat Detection Service

whitePaper | May 26, 2022

Clinical trials are becoming more complex and a confluence of forces—including the ongoing COVID-19 pandemic, greater emphasis on patient experience, increasing protocol complexity, and precise value differentiation—is accelerating this complexity. Trials have evolved to include an ever-expanding array of data sources, increased data volume and precision, decentralized clinical trials (DCT), and adaptive designs.

whitePaper | September 2, 2022

This year, unlike previous years, we asked professionals the most difficult elements of a successful data strategy instead of the most important.

whitePaper | June 16, 2022

It seems like the business world has gone crazy for machine learning (ML) and artificial intelligence (AI), viewing the technologies as the essential keys to the very future of the enterprise. In fact, a recent survey from ESIThoughtLab found that two-thirds of business leaders see AI as critically important for their future. And yet, the respondents report that only 25% of AI projects are in widespread deployment and 40% of all projects are generating negative or no returns.

whitePaper | February 26, 2020

El cambio de paradigma que se está extendiendo por el ámbito tecnológico y empresarial es cada día más evidente. La transición a cloud computing está llegando a su punto de inflexión. Las fusiones y adquisiciones han proliferado. Además, con un número cada vez mayor de usuarios finales que operan fuera del entorno empresarial, los departamentos de TI deben prestar servicio a un ecosistema de usuarios cada vez más diverso, distribuido y exigente

whitePaper | December 5, 2022

When modern LIMS software overtook traditional paper-based record-keeping in the lab, operations in every industry improved. Automated data collection drove efficiencies at the bench. Cloud solutions accelerated knowledge-sharing between partners. Built-in security and permission features enhanced data integrity. There’s hardly a lab in operation right now that hasn’t gained from this leap towards digital transformation.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.